Navigation Links
HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
Date:12/7/2010

nd strokes. Infections are common, and chronic damage occurs in many organs, including the spleen, bones, kidneys, lungs, brain, and eyes. The sole drug which is approved to treat the disease is a cancer chemotherapy drug, hydroxyurea.  The lifespan of sickle cell patients is markedly reduced.

Beta thalassemias are among the most common genetic blood disorders worldwide. Patients are unable to produce normal amounts of the beta hemoglobin chain of adult hemoglobin and, therefore, experience consequent rapid destruction of red blood cells and their progenitors, and moderate to severe, transfusion-dependent anemia. The standard therapies are transplantation and red blood cell transfusions, which cause iron overload and vital organ damage, and must be treated with iron chelator drugs.  

ABOUT HEMAQUEST PHARMACEUTICALS, INC.HemaQuest Pharmaceuticals (www.HemaQuest.com), established in late 2007, is a San Diego and Seattle-based biopharmaceutical company focused on developing small molecule therapeutics based on its proprietary SCFAD technologies to treat hemoglobin diseases. HemaQuest is also developing a second therapy for viral-related hematologic malignancies. The Company's investors include De Novo Ventures, Forward Ventures, Lilly Ventures, Aberdare Ventures and Latterell Venture Partners.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks an
'/>"/>

SOURCE HemaQuest Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
2. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
3. Aires Pharmaceuticals, Inc. Completes $20M Equity Financing and Signs an Option Agreement with a Major Pharmaceutical Company
4. Omthera Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
5. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
8. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
9. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
10. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
11. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  A new way for ... for their own health and first aid, is being introduced ... This campaign has a funding goal of $70,000, which needs ... and first aid bracelet to market. This device was inspired ... and the fact that emergencies occur every day. While medical ...
(Date:6/30/2015)... , June 30, 2015 Dipexium Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... closing of its previously announced underwritten public offering ... also exercised their over-allotment option in full to ... The net proceeds to Dipexium are ...
(Date:6/30/2015)... Pulse Light Clinic in ... sufferers as part of their ongoing research into the condition. ... for their Rosacea. The survey participants were aged between 20 ... 53% women. The results revealed some rather surprising ... or attempt to visit their GP for Rosacea treatment. ...
Breaking Medicine Technology:Amyko Propels Medical Alert Bracelets Into the Modern Era 2Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 384% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3
... 1 Researchers have found,that a gene region ... of adult,rheumatoid arthritis is also present in all ... gene may be a "master switch" that,helps turn ... Children,s Hospital of Philadelphia reported on the,link between ...
... of multidrug-resistant,Gram-negative bacteria has necessitated the use of ... known nephrotoxicity. Now Northern Antibiotics,Ltd, a Finnish biotech ... preclinical studies show signs of lower nephrotoxicity., ... polymyxin B,and colistin have five. They bind to ...
Cached Medicine Technology:Pediatric Researchers Find Possible 'Master Switch' Gene in Juvenile Arthritis 2Pediatric Researchers Find Possible 'Master Switch' Gene in Juvenile Arthritis 3Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity 2
(Date:6/30/2015)... Angeles, CA (PRWEB) , ... June 30, 2015 , ... ... You Have Acne ,” listed five triggers that most people would not expect ... hair care products, and toothpaste. The primary causes of acne are clogged ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... reported today it has more than doubled the size of its medical staff ... center’s medical staff -- which includes physicians, nurse practitioners and physician assistants -- ...
(Date:6/30/2015)... ... 30, 2015 , ... Family and professional dementia caregivers are ... November 9, 2015 at the Hyatt Regency Denver Tech Center from 7:30 am-4:30 ... Ashley Campbell, the wife and daughter of singer Glen Campbell, who will discuss ...
(Date:6/30/2015)... NJ (PRWEB) , ... June 30, 2015 , ... From ... they will be wowed with the incredible care that they receive and the luxury ... for their patients; but now they are proud to offer the same experience, just ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Dr. Sammy ... care sports medicine physician. He specializes in the diagnosis and treatment of non-surgical sports ... for the people who participate in recreational athletics and use exercise to stay healthy ...
Breaking Medicine News(10 mins):Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5
... http://www.nhs.uk ), the,digital ,front door, to the NHS, ... people improve their fitness levels., Based on ... enables users,to get the low down on the ... with clinically approved guidance to help them improve ...
... worms are shedding new light on the hormone,s role in ... gained new insight into the workings of insulin, potentially laying ... has only taken place in worms, a common model for ... if it will translate to humans. But worms whose insulin ...
... The Association for Professionals in Infection Control and ... combat Clostridium difficile-associated disease (CDAD). The initiative begins ... a better understanding of the spread of this ... bacterium that causes diarrhea and more serious intestinal ...
... 20, 2008 A bodysuit that heats or cools ... is providing multiple sclerosis researchers at UT Southwestern Medical ... link between body temperature and severity of MS symptoms. ... Uhthoffs phenomenon, named for the German ophthalmologist who reported ...
... not inevitable with improved treatment and prevention of chronic ... ... Milken Institute, the annual economic impact on,Ohio,s economy of the most common chronic ... cost is a staggering $1,trillion, which could balloon to nearly $6 trillion by ...
... The Cystic Fibrosis,Foundation announced today it has ... from Charity Navigator, the largest charity,evaluator in the ... of four possible stars for achieving,excellence in fiscal ... majority of nonprofits in America with respect to ...
Cached Medicine News:Health News:Tweaking Insulin Might Help Fight Aging 2Health News:APIC launches first national C. difficile prevalence study 2Health News:Eye test peers into heat-related multiple sclerosis symptoms 2Health News:Annual Economic Impact of Chronic Disease on Ohio Economy is $56.8 Billion 2Health News:Annual Economic Impact of Chronic Disease on Ohio Economy is $56.8 Billion 3Health News:Cystic Fibrosis Foundation Receives Coveted 4-Star Rating for Sound Fiscal Management From Charity Navigator 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: